Literature DB >> 21125267

Identification of mannose uptake and catabolism genes in Corynebacterium glutamicum and genetic engineering for simultaneous utilization of mannose and glucose.

Miho Sasaki1, Haruhiko Teramoto, Masayuki Inui, Hideaki Yukawa.   

Abstract

Here, focus is on Corynebacterium glutamicum mannose metabolic genes with the aim to improve this industrially important microorganism's ability to ferment mannose present in mixed sugar substrates. cgR_0857 encodes C. glutamicum's protein with 36% amino acid sequence identity to mannose 6-phosphate isomerase encoded by manA of Escherichia coli. Its deletion mutant did not grow on mannose and exhibited noticeably reduced growth on glucose as sole carbon sources. In effect, C. glutamicum manA is not only essential for growth on mannose but also important in glucose metabolism. A double deletion mutant of genes encoding glucose and fructose permeases (ptsG and ptsF, respectively) of the phosphoenolpyruvate-dependent phosphotransferase system (PTS) was not able to grow on mannose unlike the respective single deletion mutants with mannose utilization ability. A mutant deficient in ptsH, a general PTS gene, did not utilize mannose. These indicate that the glucose-PTS and fructose-PTS are responsible for mannose uptake in C. glutamicum. When cultured with a glucose and mannose mixture, mannose utilization of manA-overexpressing strain CRM1 was significantly higher than that of its wild-type counterpart, but with a strong preference for glucose. ptsF-overexpressing strain CRM2 co-utilized mannose and glucose, but at a total sugar consumption rate much lower than that of the wild-type strain and CRM1. Strain CRM3 overexpressing both manA and ptsF efficiently co-utilized mannose and glucose. Under oxygen-deprived conditions, high volumetric productivity of organic acids concomitant with the simultaneous consumption of the mixed sugars was achieved by the densely packed growth-arrested CRM3 cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21125267     DOI: 10.1007/s00253-010-3002-8

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  7 in total

1.  Investigation of ptsG gene in response to xylose utilization in Corynebacterium glutamicum.

Authors:  Chen Wang; Heng Cai; Zhihui Zhou; Kai Zhang; Zhongjun Chen; Yali Chen; Honggui Wan; Pingkai Ouyang
Journal:  J Ind Microbiol Biotechnol       Date:  2014-05-25       Impact factor: 3.346

2.  Enhanced Glucose Consumption and Organic Acid Production by Engineered Corynebacterium glutamicum Based on Analysis of a pfkB1 Deletion Mutant.

Authors:  Satoshi Hasegawa; Yuya Tanaka; Masako Suda; Toru Jojima; Masayuki Inui
Journal:  Appl Environ Microbiol       Date:  2017-01-17       Impact factor: 4.792

3.  Metabolism of Toxic Sugars by Strains of the Bee Gut Symbiont Gilliamella apicola.

Authors:  Hao Zheng; Alex Nishida; Waldan K Kwong; Hauke Koch; Philipp Engel; Margaret I Steele; Nancy A Moran
Journal:  MBio       Date:  2016-11-01       Impact factor: 7.867

4.  Online estimation of changing metabolic capacities in continuous Corynebacterium glutamicum cultivations growing on a complex sugar mixture.

Authors:  Peter Sinner; Marlene Stiegler; Oliver Goldbeck; Gerd M Seibold; Christoph Herwig; Julian Kager
Journal:  Biotechnol Bioeng       Date:  2021-12-11       Impact factor: 4.395

5.  Transcriptional and metabolic effects of glucose on Streptococcus pneumoniae sugar metabolism.

Authors:  Laura Paixão; José Caldas; Tomas G Kloosterman; Oscar P Kuipers; Susana Vinga; Ana R Neves
Journal:  Front Microbiol       Date:  2015-10-07       Impact factor: 5.640

Review 6.  Bio-based production of organic acids with Corynebacterium glutamicum.

Authors:  Stefan Wieschalka; Bastian Blombach; Michael Bott; Bernhard J Eikmanns
Journal:  Microb Biotechnol       Date:  2012-12-02       Impact factor: 5.813

7.  L-citrulline production by metabolically engineered Corynebacterium glutamicum from glucose and alternative carbon sources.

Authors:  Dorit Eberhardt; Jaide V K Jensen; Volker F Wendisch
Journal:  AMB Express       Date:  2014-12-10       Impact factor: 3.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.